相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Sleep Duration, Health Promotion Index, sRAGE, and ApoE-ε4 Genotype Are Associated With Telomere Length in Healthy Australians
Varinderpal S. Dhillon et al.
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2022)
Apolipoprotein E ε4 Allele is Associated With Plasma Amyloid Beta and Amyloid Beta Transporter Levels: A Cross-sectional Study in a Rural Area of Xi'an, China
Shan Wei et al.
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY (2020)
Letter to the Editor, Reacting to: APOE epsilon 4 Carriers Have a Greater Propensity to Glycation and sRAGE Which Is Further Influenced by RAGE G82S Polymorphism
Sanne S. Mooldijk et al.
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2020)
Relationship Between Peripheral Transport Proteins and Plasma Amyloid-β in Patients with Alzheimer's Disease Were Different from Cognitively Normal Controls: A Propensity Score Matching Analysis
Ling Gao et al.
JOURNAL OF ALZHEIMERS DISEASE (2020)
The soluble receptor for advanced glycation end-products (sRAGE) has a dual phase-dependent association with residual cardiovascular risk after an acute coronary event
Helena Grauen Larsen et al.
ATHEROSCLEROSIS (2019)
Lag-time in Alzheimer's disease patients: a potential plasmatic oxidative stress marker associated with ApoE4 isoform
Luca Massaccesi et al.
IMMUNITY & AGEING (2019)
APOE ε4 carriers have a greater propensity to glycation and sRAGE which is further influenced by RAGE G82S polymorphism
Permal Deo et al.
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2019)
Amyloid-β immunotherapy for alzheimer disease: Is it now a long shot?
Francesco Panza et al.
ANNALS OF NEUROLOGY (2019)
Pulse pressure is associated with plasma amyloid-β transport dysfunction
Yu Jiang et al.
JOURNAL OF HYPERTENSION (2018)
The Level of Plasma Amyloid-β40 Is Correlated with Peripheral Transport Proteins in Cognitively Normal Adults: A Population-Based Cross-Sectional Study
Ling Gao et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
Montreal Cognitive Assessment and Mini-Mental State Examination reliable change indices in healthy older adults
Miloslav Kopecek et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2017)
Plasma levels of soluble receptor for advanced glycation end products in Alzheimer's disease
Xiao-Yan Xu et al.
INTERNATIONAL JOURNAL OF NEUROSCIENCE (2017)
Association between advanced glycation end-products and functional performance in Alzheimer's disease and mixed dementia
Hans Drenth et al.
INTERNATIONAL PSYCHOGERIATRICS (2017)
Sleep Deprivation Induced Plasma Amyloid-beta Transport Disturbance in Healthy Young Adults
Meng Wei et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
The amyloid hypothesis of Alzheimer's disease at 25years
Dennis J. Selkoe et al.
EMBO MOLECULAR MEDICINE (2016)
Receptor for advanced glycation endproduct modulators: a new therapeutic target in Alzheimer's disease
Douglas Walker et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2015)
Clearance systems in the brain-implications for Alzheimer disease
Jenna M. Tarasoff-Conway et al.
NATURE REVIEWS NEUROLOGY (2015)
Receptor for advanced glycation end-products in neurodegenerative diseases
Judyta Juranek et al.
REVIEWS IN THE NEUROSCIENCES (2015)
Cellular signalling of the receptor for advanced glycation end products (RAGE)
Jianling Xie et al.
CELLULAR SIGNALLING (2013)
Decreased plasma levels of soluble low density lipoprotein receptor-related protein-1 (sLRP) and the soluble form of the receptor for advanced glycation end products (sRAGE) in the clinical diagnosis of Alzheimer's disease
Furu Liang et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2013)
Assessing cognitive changes in the elderly: Reliable Change Indices for the Mini-Mental State Examination
J. Stein et al.
ACTA PSYCHIATRICA SCANDINAVICA (2012)
National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease
Bradley T. Hyman et al.
ALZHEIMERS & DEMENTIA (2012)
Impaired Lipoprotein Receptor-Mediated Peripheral Binding of Plasma Amyloid-beta is an Early Biomarker for Mild Cognitive Impairment Preceding Alzheimer's Disease
Abhay P. Sagare et al.
JOURNAL OF ALZHEIMERS DISEASE (2011)
Association between the RAGE G82S polymorphism and Alzheimer's disease
Keshen Li et al.
JOURNAL OF NEURAL TRANSMISSION (2010)
RAGE and Alzheimer's Disease: A Progression Factor for Amyloid-beta-Induced Cellular Perturbation?
Shi Du Yan et al.
JOURNAL OF ALZHEIMERS DISEASE (2009)
A soluble form of the receptor for advanced glycation endproducts (RAGE) is produced by proteolytic cleavage of the membrane-bound form by the sheddase a disintegrin and metalloprotease 10 (ADAM10)
Angela Raucci et al.
FASEB JOURNAL (2008)
Receptor for Advanced Glycation End Products Is Subjected to Protein Ectodomain Shedding by Metalloproteinases
Ling Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Decreased plasma levels of soluble receptor for advanced glycation end products in mild cognitive impairment
R. Ghidoni et al.
JOURNAL OF NEURAL TRANSMISSION (2008)
Measuring cognitive change in older adults: reliable change indices for the Mini-Mental State Examination
A. Hensel et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2007)
Clearance of amyloid-β by circulating lipoprotein receptors
Abhay Sagare et al.
NATURE MEDICINE (2007)
Serum levels of sRAGE, the soluble form of receptor for advanced glycation end products, are associated with inflammatory markers in patients with type 2 diabetes
Kazuo Nakamura et al.
MOLECULAR MEDICINE (2007)
Receptor for advanced glycation end-products is a marker of type I cell injury in acute lung injury
T Uchida et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2006)
Soluble receptor for advanced glycation end products in patients with decreased renal function
M Kalousová et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2006)
Circulating levels of soluble receptor for advanced glycation end products in Alzheimer disease and vascular dementia
E Emanuele et al.
ARCHIVES OF NEUROLOGY (2005)
RAGE (Yin) versus LRP (Yang) balance regulates Alzheimer amyloid β-peptide clearance through transport across the blood-brain barrier
R Deane et al.
STROKE (2004)
RAGE mediates amyloid-β peptide transport across the blood-brain barrier and accumulation in brain
R Deane et al.
NATURE MEDICINE (2003)
Role of apoE/Aβ interactions in the pathogenesis of Alzheimer's disease and cerebral amyloid angiopathy
DM Holtzman
JOURNAL OF MOLECULAR NEUROSCIENCE (2001)
分享论文
